Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139165
Status:
UNKNOWN
Last Update Posted:
2008-03-06
First Post:
2005-08-29
Brief Title:
Long-Term Treatment of Collagenous Colitis With Budesonide
Sponsor:
Bonderup Ole K MD
Organization:
Bonderup Ole K MD
Study Overview
Official Title:
Long-Term Treatment of Collagenous Colitis With Budesonide Prospective Doubleblind Placebo-Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2005-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide The end poit is effect on clinical symptoms number of daily stools
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None